Gastrointestinal symptoms in 342 patients with Fabry disease: prevalence and response to enzyme replacement therapy.
BACKGROUND and AIMS: Fabry disease is an X-linked deficiency of alpha-galactosidase A, resulting in lysosomal deposition of globotriaosylceramide in nearly all tissues. The disease frequently causes diarrhea and abdominal pain, which are assumed to arise from malfunction of enteric neurons and which...
Main Authors: | Hoffmann, B, Schwarz, M, Mehta, A, Keshav, S |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2007
|
Similar Items
-
Nature and prevalence of gastrointestinal symptoms in Fabry disease - A retrospective analysis from the Fabry Outcome Survey
by: Hoffmann, B, et al.
Published: (2006) -
Gastrointestinal symptoms in Fabry disease: Data from the Fabry outcome survey
by: Hoffmann, B, et al.
Published: (2006) -
Gastrointestinal symptoms in Fabry disease: everything is possible, including treatment.
by: Hoffmann, B, et al.
Published: (2007) -
Enzyme Replacement Therapy in the Treatment of Fabry Disease
by: YU Che, et al.
Published: (2023-07-01) -
Enzyme replacement reverses abnormal cerebrovascular responses in Fabry disease
by: Herscovitch Peter, et al.
Published: (2002-06-01)